2022 annual financial data
Pliant Therapeutics 2022 Operating margin
Pliant Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -1,313.37%.
Operating income was -127,200,000 USD and net income was -123,321,000 USD.
Operating cash flow was -94,631,000 USD.
Get free Pliant Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,685,000 USD
- Operating income
- -127,200,000 USD
- Net income
- -123,321,000 USD
- Operating cash flow
- -94,631,000 USD